Surrogacy Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 2 Billion |
| Market Size (2029) | USD 5.47 Billion |
| CAGR (2024 - 2029) | 22.29 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Surrogacy Market Analysis
The Surrogacy Market size is estimated at USD 2 billion in 2024, and is expected to reach USD 5.47 billion by 2029, growing at a CAGR of 22.29% during the forecast period (2024-2029).
Factors such as the increasing number of infertility cases globally, the sedentary lifestyle of people, the growing number of fertility clinics, and rising awareness about assisted reproductive technology, such as in-vitro fertilization (IVF) and surrogacy, are expected to boost the market growth over the forecast period.
Infertility is becoming an increasing challenge owing to multiple factors such as environment, genetics, age, and comorbidities that have been associated with impaired reproductive function. For instance, according to the data published by the World Health Organization in April 2023, it was observed that about 17.5% of the adult population, roughly 1 in 6 worldwide, may experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need. Additionally, an article published in Cell Journal in May 2022 stated that male infertility is an increasing and serious medical concern that affects approximately half of infertile couples worldwide. Thus, the growing number of infertility cases has increased the demand for fertility procedures using assisted reproductive technology (ART), such as surrogacy, which, in turn, is anticipated to fuel the market growth over the forecast period.
Additionally, demographic changes and ongoing lifestyle disorders like obesity, anxiety, and stress cause delayed childbearing. Some of the prevalent causes of infertility are imbalances in hormones, sexually transmitted diseases, and polycystic ovary syndrome (PCOS). For instance, in an article published by Gynaecology and Obstetrics in January 2023, it was highlighted that individuals dealing with obesity encounter heightened challenges in accessing fertility treatments and realizing successful pregnancies. Moreover, the significant impact of obesity on implantation and live birth rates often results in infertility. Consequently, the prevalence of obesity among women increases the likelihood of turning to surrogacy, which is expected to fuel the market growth over the forecast period.
Furthermore, the rising number of fertility clinics globally, owing to the increasing fertility issues among the population, is expected to propel the demand for fertility treatments such as surrogacy. For instance, in May 2023, Generation Prime launched its first two fertility clinics in Bangkok and Kuala Lumpur. The clinics provide initial consultations and include egg and sperm freezing, diagnosis, testing, IVF, and surrogacy. Also, Generation Prime plans to open a total of 15 clinics in Thailand, Malaysia, and Singapore. Similarly, in December 2022, Kindbody launched a state-of-the-art clinic and in-vitro fertilization (IVF) lab in Dallas, Texas, United States. This launch assists Kindbody in meeting the increasing demand for world-class fertility care.
Therefore, the market is anticipated to grow over the forecast period due to the aforementioned factors, such as the high burden of infertility, increasing IVF awareness campaigns, and the growing number of IVF facilities and products. However, the complications associated with in-vitro fertilization, as well as social stigma and ethical and legal issues associated with it, may hinder the growth of the market over the forecast period.
Surrogacy Market Trends
The IVF with Intracytoplasmic Sperm Injection Segment is Expected to Witness Significant Growth Over the Forecast Period
Intracytoplasmic sperm injection (ICSI) is an in-vitro fertilization technique during which a single sperm can be injected directly into the egg for fertilization.
The in-vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) segment is expected to grow over the forecast period, owing to factors such as the rising number of infertility cases among the population. Factors such as smoking, taking antibiotics, depression, and other health conditions, growing demand for surrogacy procedures, and the increasing awareness among the population regarding assisted reproductive technology (ART) procedures are also expected to facilitate market growth.
In addition, the emerging advanced technologies used for fertility procedures and growing government initiatives are also expected to fuel IVF with intracytoplasmic sperm injection procedures, which, in turn, is expected to augment the segment growth over the forecast period.
The use of ICSI has increased globally, mainly in couples with non-male factors. IVF with ICSI facilitates the selection of sperm with good morphological characteristics, increases the chances of fertilization of eggs and the quality of potentially usable embryos, and avoids fertilization failure rates. Such advantages offered by ICSI make it a primary choice for couples with infertility issues and poor ovarian response.
The growing awareness and government initiatives to regulate surrogacy and increasing coverage of IVF under insurance are the other major factors that are expected to play a crucial role in the growth of the studied segment. For instance, in June 2022, the Indian state Odisha constituted a state-appropriate authority and set up the state-assisted reproductive technology and surrogacy board with the objective of regulating IVF clinics and prohibiting commercial surrogacy. With surrogacy becoming popular, the Assisted Reproductive Technology (ART) Act came as a ray of hope for infertile couples who have been battling legal, ethical, and social tussles.
Furthermore, the increasing launches of IVF facilities and new technologies across the globe to provide better ART services, including surrogacy, are also contributing to the segment growth. For instance, in November 2022, Oma Fertility partnered with agency partners to integrate technology into fertility care. Oma focuses on helping couples conceive by bringing artificial intelligence and robotics to in-house fertility treatments as well as collaborating with third parties such as surrogate agencies and egg and sperm banks.
Therefore, owing to factors such as the increasing government and hospital initiatives, rising launches of IVF facilities, and introduction of advanced technologies, the in-vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) segment is expected to grow over the forecast period.
North America is Expected to Hold Significant Market Share Over the Forecast Period
North America is anticipated to witness a significant share in the surrogacy market over the forecast period owing to factors such as the rising prevalence of polycystic ovary syndrome (PCOS) among women and a constant rise in infertility cases. In addition, the presence of various leading players in this region, the growing number of single women and same-sex couples, and favorable regulatory reforms are also expected to boost the market growth.
The burden of infertility cases among the population is the key factor driving the demand for in-vitro fertilization treatments, which, in turn, is anticipated to augment the growth of the market over the forecast period. For instance, according to an article published in Advances in the Management of Infertility in February 2023, it was observed that about 12% to 15% of the reproductive-age population of women in the United States had difficulty conceiving at some point in their lives.
Additionally, the rising focus of the centers and organizations to launch various surrogacy programs is anticipated to fuel the adoption of surrogacy procedures among infertile couples in the region, which is expected to augment the market growth over the forecast period. For instance, in September 2022, Pinnacle Fertility launched Pinnacle Surrogacy, a gestational surrogacy program, to support patients undergoing treatment at a network clinic who need a gestational carrier (surrogate) to start or grow their family. It offers exceptional client services, high-quality surrogates, and expedited surrogate matching to Pinnacle network patients.
The rising adoption of various key strategic activities such as acquisitions, collaborations, and agreements among fertility clinics and hospitals is expected to increase the availability of different surrogacy procedures in the region. For instance, in August 2022, Kindbody, a US-based fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care, acquired Alternative Reproductive Resources (ARR), a gestational surrogacy agency. The acquisition incorporated gestational surrogacy in-house, delivering a seamless continuum of patient care.
Furthermore, the launches of new fertility centers in the region are expected to fuel the demand for surrogacy treatment among the population, hence anticipated to contribute to the market growth. For instance, in August 2023, GoStork, United States, launched its Fertility Clinic Marketplace, a first-of-its-kind platform that takes a data-driven, customized approach to match fertility consumers with clinics based on their age, budget, personal needs, and unique fertility journey. The new Fertility Clinic Marketplace offers surrogacy agencies, egg donor agencies, and fertility financing, as well as one-on-one, personalized concierge services.
Moreover, the growing initiatives to promote the adoption of surrogacy across the region are further anticipated to augment the market growth. For instance, in May 2023, Conceive Abilities launched a Trailblazing DC Surrogate Compensation Package in the United States, in which surrogates can earn up to USD 72,000 with a limited-time bonus.
Therefore, owing to increasing infertility cases, the introduction of surrogacy programs and platforms, and the growing initiatives by companies, the market studied is anticipated to grow over the forecast period.
Surrogacy Industry Overview
The surrogacy market is fragmented and competitive owing to the presence of a large number of fertility clinics and hospitals. The fertility clinics and hospitals are adopting key strategic activities, such as collaborations, acquisitions, and new platform launches, which may help in promoting surrogacy procedures among the population. Some of the key players in the market include IVI RMA Global, Houston Fertility Center, Ovation Fertility, Max Healthcare, and Clinic Scanfert.
Surrogacy Market Leaders
-
IVI RMA Global
-
Houston Fertility Center
-
Ovation Fertility
-
Max Healthcare
-
Clinic Scanfert
*Disclaimer: Major Players sorted in no particular order
Surrogacy Market News
- May 2024: Apollo Hospitals Enterprise Ltd launched its first standalone fertility center in Chennai, India, to offer quality infertility treatment.
- April 2024: Amrita Hospital, Kochi, India, launched a new Amrita Fertility Centre in Vyttila. The newly launched center offers a wide range of services, including in-vitro fertilization, intrauterine insemination, early cleavage, advanced fertility consultation and assessment, detailed sperm assessment, hystero-laparoscopic surgery, and fertility counseling.
Surrogacy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Number of Infertility Cases Globally Coupled with Sedentary Lifestyle
- 4.2.2 Growing Number of Fertility Clinics
- 4.2.3 Increasing Awareness About Assisted Reproductive Technology Such as IVF and Surrogacy
-
4.3 Market Restraints
- 4.3.1 Stringent Regulations About Commercial Surrogacy
- 4.3.2 High Cost Involved in Surrogacy Procedure
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Type
- 5.1.1 Gestational Surrogacy
- 5.1.2 Traditional Surrogacy
-
5.2 By Technology
- 5.2.1 IVF with Intracytoplasmic Sperm Injection (ICSI)
- 5.2.2 IVF without Intracytoplasmic Sperm Injection (ICSI)
- 5.2.3 Intrauterine Insemination (IUI)
-
5.3 By Service Provider
- 5.3.1 Hospitals
- 5.3.2 Fertility Centers
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 IVI RMA Global
- 6.1.2 Houston Fertility Center
- 6.1.3 Clinic Scanfert
- 6.1.4 Nova IVI Fertility
- 6.1.5 Ovation Fertility
- 6.1.6 Max Healthcare
- 6.1.7 Circle Surrogacy and IVF Center
- 6.1.8 Care Fertility
- 6.1.9 Bourn Hall Clinic
- 6.1.10 Pacific Fertility Center Los Angeles
- 6.1.11 Fertility Center of San Antonio
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySurrogacy Industry Segmentation
Surrogacy is a method of assisted reproductive technology in which the surrogate carries a baby and takes care of the baby until birth. In this procedure, the embryo is developed through an in-vitro fertilization procedure (IVF) using the eggs and sperm of the intended parents. The embryo is then transferred to the surrogate mother.
The surrogacy market is segmented by type, technology, service provider, and geography. By type, the market is segmented into gestational surrogacy and traditional surrogacy. By technology, the market is segmented into IVF with intracytoplasmic sperm injection (ICSI), IVF without intracytoplasmic sperm injection (ICSI), and intrauterine insemination (IUI). By service provider, the market is segmented into hospitals and fertility centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size and forecast are provided in terms of value (USD).
| By Type | Gestational Surrogacy | |
| Traditional Surrogacy | ||
| By Technology | IVF with Intracytoplasmic Sperm Injection (ICSI) | |
| IVF without Intracytoplasmic Sperm Injection (ICSI) | ||
| Intrauterine Insemination (IUI) | ||
| By Service Provider | Hospitals | |
| Fertility Centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Surrogacy Market Research FAQs
How big is the Surrogacy Market?
The Surrogacy Market size is expected to reach USD 2 billion in 2024 and grow at a CAGR of 22.29% to reach USD 5.47 billion by 2029.
What is the current Surrogacy Market size?
In 2024, the Surrogacy Market size is expected to reach USD 2 billion.
Who are the key players in Surrogacy Market?
IVI RMA Global, Houston Fertility Center, Ovation Fertility, Max Healthcare and Clinic Scanfert are the major companies operating in the Surrogacy Market.
Which is the fastest growing region in Surrogacy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Surrogacy Market?
In 2024, the North America accounts for the largest market share in Surrogacy Market.
What years does this Surrogacy Market cover, and what was the market size in 2023?
In 2023, the Surrogacy Market size was estimated at USD 1.55 billion. The report covers the Surrogacy Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Surrogacy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Surrogacy Industry Report
Statistics for the 2024 Surrogacy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Surrogacy analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
